Condition
Hyperkalaemia clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hyperkalaemia clinical trials that are recruiting, at sites in 14 countries (most in Brazil (1), Canada (1), China (1)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 14Countries
All recruiting trials (2)
-
Patiromer to allow more flexible potassium diets and improve quality of life for people on chronic dialysis
This trial will test whether giving patiromer to people on chronic hemodialysis lets them relax potassium restrictions in their diet without raising their risk of high blood potassium.
-
Assessing the safety and efficacy of sodium zirconium cyclosilicate in children with hyperkalaemia
This study is testing a new medication called sodium zirconium cyclosilicate to see if it can safely help children with high potassium levels feel better and keep their potassium in a normal range.
Related topics
Quick answers
How many Hyperkalaemia clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in Brazil (1 trial), Canada (1 trial), China (1 trial), Germany (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.